• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

形态学状态对肝内胆管细胞癌患者肝切除术后长期预后的影响。

Impact of Morphological Status on Long-Term Outcome Among Patients Undergoing Liver Surgery for Intrahepatic Cholangiocarcinoma.

机构信息

Department of Surgery, University of Verona, Verona, Italy.

Department of Surgery, Johns Hopkins Hospital, Baltimore, MD, USA.

出版信息

Ann Surg Oncol. 2017 Sep;24(9):2491-2501. doi: 10.1245/s10434-017-5870-y. Epub 2017 May 2.

DOI:10.1245/s10434-017-5870-y
PMID:28466403
Abstract

BACKGROUND

The influence of morphological status on the long-term outcome of patients undergoing liver resection for intrahepatic cholangiocarcinoma (ICC) is poorly defined. We sought to study the impact of morphological status on overall survival (OS) of patients undergoing curative-intent resection for ICC.

METHODS

A total of 1083 patients who underwent liver resection for ICC between 1990 and 2015 were identified. Data on clinicopathological characteristics, operative details, and morphological status were recorded and analyzed. A propensity score-matched analysis was performed to reduce confounding biases.

RESULTS

Among 1083 patients, 941(86.9%) had a mass-forming (MF) or intraductal-growth (IG) type, while 142 (13.1%) had a periductal-infiltrating (PI) or MF with PI components (MF + PI) ICC. Patients with an MF/IG ICC had a 5-year OS of 41.8% (95% confidence interval [CI] 37.7-45.9) compared with 25.5% (95% CI 17.3-34.4) for patients with a PI/MF + PI (p < 0.001). Morphological type was found to be an independent predictor of OS as patients with a PI/MF + PI ICC had a higher hazard of death (hazard ratio [HR] 1.42, 95% CI 1.11-1.82; p = 0.006) compared with patients who had an MF/IG ICC. Compared with T1a-T1b-T2 MF/IG tumors, T1a-T1b-T2 PI/MF + PI and T3-T4 PI/MF + PI tumors were associated with an increased risk of death (HR 1.47 vs. 3.59). Conversely, patients with T3-T4 MF/IG tumors had a similar risk of death compared with T1a-T1b-T2 MF/IG patients (p = 0.95).

CONCLUSION

Among patients undergoing curative-intent resection of ICC, morphological status was a predictor of long-term outcome. Patients with PI or MF + PI ICC had an approximately 45% increased risk of death long-term compared with patients who had an MF or IG ICC.

摘要

背景

形态学状态对接受肝切除术治疗肝内胆管细胞癌(ICC)患者长期预后的影响尚不清楚。我们旨在研究形态学状态对接受根治性切除的 ICC 患者总生存(OS)的影响。

方法

共纳入 1990 年至 2015 年间接受肝切除术治疗 ICC 的 1083 例患者。记录并分析了临床病理特征、手术细节和形态学状态等数据。采用倾向评分匹配分析来减少混杂偏倚。

结果

在 1083 例患者中,941 例(86.9%)为肿块型(MF)或内胆管生长型(IG),142 例(13.1%)为壁内浸润型(PI)或 MF 伴 PI 成分(MF+PI)ICC。MF/IG ICC 患者的 5 年 OS 为 41.8%(95%置信区间 [CI] 37.7-45.9),而 PI/MF+PI 患者的 5 年 OS 为 25.5%(95% CI 17.3-34.4)(p<0.001)。形态学类型是 OS 的独立预测因素,因为 PI/MF+PI ICC 患者的死亡风险更高(危险比 [HR] 1.42,95% CI 1.11-1.82;p=0.006),而 MF/IG ICC 患者的死亡风险较低。与 T1a-T1b-T2 MF/IG 肿瘤相比,T1a-T1b-T2 PI/MF+PI 和 T3-T4 PI/MF+PI 肿瘤与死亡风险增加相关(HR 1.47 vs. 3.59)。相反,与 T1a-T1b-T2 MF/IG 患者相比,T3-T4 MF/IG 肿瘤患者的死亡风险相似(p=0.95)。

结论

在接受根治性切除 ICC 的患者中,形态学状态是长期预后的预测因素。与 MF/IG ICC 患者相比,PI 或 MF+PI ICC 患者的死亡风险增加约 45%。

相似文献

1
Impact of Morphological Status on Long-Term Outcome Among Patients Undergoing Liver Surgery for Intrahepatic Cholangiocarcinoma.形态学状态对肝内胆管细胞癌患者肝切除术后长期预后的影响。
Ann Surg Oncol. 2017 Sep;24(9):2491-2501. doi: 10.1245/s10434-017-5870-y. Epub 2017 May 2.
2
Intrahepatic cholangiocarcinoma: prognostic factors after surgical resection.肝内胆管癌:手术切除后的预后因素
World J Surg. 2009 Jun;33(6):1247-54. doi: 10.1007/s00268-009-9970-0.
3
Clinicopathological characteristics of intrahepatic cholangiocellular carcinoma presenting intrahepatic bile duct growth.呈现肝内胆管生长的肝内胆管细胞癌的临床病理特征
J Surg Oncol. 2009 Mar 1;99(3):161-5. doi: 10.1002/jso.21214.
4
Long-term outcomes of patients with intraductal growth sub-type of intrahepatic cholangiocarcinoma.肝内胆管细胞癌管内生长型患者的长期预后。
HPB (Oxford). 2018 Dec;20(12):1189-1197. doi: 10.1016/j.hpb.2018.05.017. Epub 2018 Jun 27.
5
Surgery for periductal infiltrating type intrahepatic cholangiocarcinoma without hilar invasion provides a better outcome than for mass-forming type intrahepatic cholangiocarcinoma without hilar invasion.对于无肝门侵犯的导管周围浸润型肝内胆管癌,手术治疗的效果优于无肝门侵犯的肿块型肝内胆管癌。
Hepatogastroenterology. 2010 Nov-Dec;57(104):1333-6.
6
Therapeutic value of lymph node dissection during hepatectomy in patients with intrahepatic cholangiocellular carcinoma with negative lymph node involvement.肝内胆管细胞癌淋巴结无转移患者肝切除术中淋巴结清扫的治疗价值
Surgery. 2009 Apr;145(4):411-6. doi: 10.1016/j.surg.2008.11.010. Epub 2009 Feb 23.
7
Impact of microvascular invasion on clinical outcomes after curative-intent resection for intrahepatic cholangiocarcinoma.微血管侵犯对肝内胆管癌根治性切除术后临床结局的影响。
J Surg Oncol. 2019 Jan;119(1):21-29. doi: 10.1002/jso.25305. Epub 2018 Nov 22.
8
Periductal infiltrating type of intrahepatic cholangiocarcinoma: a rare macroscopic type without any apparent mass.肝内胆管细胞癌的导管周围浸润型:一种罕见的无明显肿块的大体类型。
Surg Today. 2012 Dec;42(12):1189-94. doi: 10.1007/s00595-012-0145-5. Epub 2012 Feb 21.
9
Surgical outcomes of the mass-forming plus periductal infiltrating types of intrahepatic cholangiocarcinoma: a comparative study with the typical mass-forming type of intrahepatic cholangiocarcinoma.肿块形成加肝内胆管癌导管周围浸润型的手术结果:与典型肿块形成型肝内胆管癌的比较研究
World J Surg. 2007 Oct;31(10):2016-22. doi: 10.1007/s00268-007-9194-0.
10
Should Utilization of Lymphadenectomy Vary According to Morphologic Subtype of Intrahepatic Cholangiocarcinoma?肝内胆管癌的形态学亚型是否应影响淋巴结清扫术的应用?
Ann Surg Oncol. 2019 Jul;26(7):2242-2250. doi: 10.1245/s10434-019-07336-5. Epub 2019 Mar 29.

引用本文的文献

1
Predicting perineural invasion of intrahepatic cholangiocarcinoma based on CT: a multicenter study.基于CT预测肝内胆管癌的神经周围侵犯:一项多中心研究
Abdom Radiol (NY). 2025 Sep 1. doi: 10.1007/s00261-025-05188-0.
2
Surgical interpretation of the WHO subclassification of intrahepatic cholangiocarcinoma: a narrative review.世界卫生组织肝内胆管癌亚型分类的外科解读:一篇综述
Surg Today. 2025 Jan;55(1):1-9. doi: 10.1007/s00595-024-02825-x. Epub 2024 Apr 2.
3
Expert Consensus on Pathological Diagnosis of Intrahepatic Cholangiocarcinoma (2022 version).
肝内胆管癌病理诊断专家共识(2022年版)
J Clin Transl Hepatol. 2023 Dec 28;11(7):1553-1564. doi: 10.14218/JCTH.2023.00118. Epub 2023 Jul 24.
4
Classification of Intrahepatic Cholangiocarcinoma into Perihilar Versus Peripheral Subtype.肝内胆管癌分为肝门周围型与肝内周围型。
Ann Surg Oncol. 2024 Feb;31(2):1232-1242. doi: 10.1245/s10434-023-14502-3. Epub 2023 Nov 6.
5
Intrahepatic cholangiocarcinoma with extensive intraductal extension of high-grade biliary intraepithelial neoplasia: a case report.肝内胆管癌伴高级别胆管上皮内瘤变广泛导管内扩展:一例报告
Surg Case Rep. 2023 Sep 18;9(1):164. doi: 10.1186/s40792-023-01748-y.
6
A surgical strategy for intrahepatic cholangiocarcinoma - the hilar first concept.肝内胆管癌的一种手术策略 - 肝门优先概念。
Langenbecks Arch Surg. 2023 Aug 7;408(1):296. doi: 10.1007/s00423-023-03023-y.
7
Neoadjuvant and Adjuvant Therapy in Intrahepatic Cholangiocarcinoma.肝内胆管癌的新辅助治疗和辅助治疗
J Clin Transl Hepatol. 2022 Jun 28;10(3):553-563. doi: 10.14218/JCTH.2021.00250. Epub 2022 Jan 4.
8
Molecular heterogeneity in intrahepatic cholangiocarcinoma.肝内胆管癌的分子异质性
World J Hepatol. 2020 Dec 27;12(12):1148-1157. doi: 10.4254/wjh.v12.i12.1148.
9
Outcome after liver resection for primary and recurrent intrahepatic cholangiocarcinoma.肝切除治疗原发性和复发性肝内胆管细胞癌的预后。
BJS Open. 2019 Sep 10;3(6):793-801. doi: 10.1002/bjs5.50217. eCollection 2019 Dec.
10
Essential updates to the surgical treatment of biliary tract cancer.胆道癌手术治疗的重要更新。
Ann Gastroenterol Surg. 2019 May 22;3(4):378-389. doi: 10.1002/ags3.12266. eCollection 2019 Jul.